Concentra (NYSE: CON) is gaining positive momentum as several major analysts, including Stephens, Wells Fargo, JPMorgan Chase, and Zacks, have issued Overweight or Buy ratings. The company is expanding its occupational health medical centers, notably opening a new center in Arlington, Virginia, near Reagan Airport, increasing its network in the Washington, D.C. area. The stock is trading at $38.18, near its 52-week high, reflecting optimism about its growth prospects. Analysts have raised price targets, signaling confidence in Concentra's future performance.
Wells Fargo shares are trading at USD 81.70 with a slight 0.12% decline, while JPMorgan Chase is up 0.16% at USD 334.07 on Pluang. Both stocks show strong investor interest, with Wells Fargo seeing 100% buy orders on the platform. These figures are current as of Oct 20, 2026, 20:31 WIB.
